Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
kou yan qing tablets
- Development stage
- Unknown
- Lead developer
- Zhejiang Kangde Pharmaceutical
- Administration
- Oral
01
Overview
Kou Yan Qing Tablets is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Zhejiang Kangde Pharmaceutical for the treatment of stomatitis and other oral inflammatory conditions. The product is composed of several botanical extracts, including Rehmannia glutinosa, Ophiopogon japonicus, Scrophularia ningpoensis, Lonicera japonica, and Lophatherum gracile. In the context of TCM, it is used to clear heat, detoxify, and nourish yin, which translates to anti-inflammatory and mucosal-protective effects in clinical practice. It is commonly prescribed for recurrent aphthous ulcers, gingivitis, and periodontitis.
- Brand names
- Kou Yan Qing
- Other names
- Kouyanqing TabletsKou Yan Qing
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)MMP9 (Matrix metalloproteinase-9)
Beyond the preview
Go deeper on kou yan qing tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on kou yan qing tablets.